Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Temozolomide wafer - Medisun Precision Medicine

Next Previous
X
Search
Drug Profile

Temozolomide wafer - Medisun Precision Medicine

Alternative Names: ACX-31 - Medisun Precision Medicine; ACX-31 wafer - Medisun Precision Medicine; Carmustine/temozolomide - Medisun Precision Medicine

Latest Information Update: 23 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Accelerating Combination Therapies
  • Developer Accelerating Combination Therapies; Medisun Precision Medicine; TuHURA Biosciences
  • Class 2 ring heterocyclic compounds; Amides; Antineoplastics; Epoxy compounds; Ethylene glycols; Imidazoles; Small molecules; Triazenes
  • Mechanism of Action Alkylating agents; DNA cross linking agents; DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Brain cancer; Solid tumours

Most Recent Events

  • 17 Oct 2024 Kintara Therapeutics has merged with TuHURA Biosciences to form TuHURA Biosciences
  • 21 Sep 2023 Discontinued - Preclinical for Brain cancer in USA (Intracerebral)
  • 21 Sep 2023 Discontinued for Solid tumours in USA (Intracerebral)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top